Paul Roepman
Science Park
Amsterdam, NH, Netherlands
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Assessing clinical decision support system tools in precision oncology: piloting ring testing.
Journal: ESMO real world data and digital oncology
Published: July 28, 2026
Systematic identification of genomic nonresponse biomarkers to cancer therapies.
Journal: ESMO real world data and digital oncology
Published: July 01, 2026
Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 07, 2026
Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers.
Journal: Nature medicine
Published: April 02, 2026
BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 10, 2026
Towards an ecosystem of clinical decision support tools for precision cancer medicine.
Journal: NPJ precision oncology
Published: December 30, 2025
Prospective evaluation of genomics-guided off-label treatment.
Journal: Nature
Published: September 02, 2025
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 16, 2025
Clinical implications of whole genome sequencing in metastatic colorectal cancer.
Journal: Oncogene
Published: June 10, 2025
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol.
Journal: International journal of cancer
Published: March 13, 2025
Real-world clinical utility of tumor whole-genome sequencing in solid cancers.
Journal: Nature medicine
Published: February 10, 2025
The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP).
Journal: ESMO open
Published: October 14, 2024
Last Updated: 09/26/2026